首页> 外文期刊>Journal of biomedical materials research, Part A >Tailoring of the dopamine coated surface with VEGF loaded heparin/poly-L-lysine particles for anticoagulation and accelerate in situ endothelialization
【24h】

Tailoring of the dopamine coated surface with VEGF loaded heparin/poly-L-lysine particles for anticoagulation and accelerate in situ endothelialization

机译:用载有VEGF的肝素/聚L-赖氨酸颗粒定制多巴胺包被的表面以抗凝并加速原位内皮化

获取原文
获取原文并翻译 | 示例
           

摘要

Coronary artery disease is a great threat to human health and is the leading killer worldwide. Percutaneous coronary intervention is the most effective therapy; however, thrombus, and restenosis caused by endothelium injury continue to be problematic after treatment. It is widely accepted that surface biofunctional modification to improve blood compatibility and accelerate endothelialization may be an effective approach to prevent the occurrence of adverse cardiac events. In this study, novel VEGF-loaded heparin/poly-l-lysine (Hep/PLL) particles were developed and immobilized on a dopamine coated titanium surface. The size, distribution, zeta potential, and morphology of the prepared particles were subsequently characterized. The influence of changes in the surface physicochemical properties after particle immobilization was assessed for blood compatibility and cytocompatibility. Surface-modified VEGF-loaded particles significantly inhibited platelet adhesion and activation and were effective in promoting the proliferation and survival of endothelial progenitor cells and endothelial cells. Moreover, Hep/PLL particles were also beneficial for controlling the long-term release of VEGF, which may facilitate endothelium regeneration. In conclusion, VEGF-loaded Hep/PLL particles were successfully immobilized on the Ti surface, and the biocompatibility was significantly improved. This study demonstrates a potential application for the multifunctional modification of stent surfaces for clinical use. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 2024-2034, 2015.
机译:冠状动脉疾病对人类健康构成巨大威胁,并且是全球范围内的主要杀手。经皮冠状动脉介入治疗是最有效的治疗方法。然而,治疗后由内皮损伤引起的血栓和再狭窄仍然存在问题。人们普遍接受表面生物功能修饰以改善血液相容性并加速内皮化可能是预防不良心脏事件发生的有效方法。在这项研究中,开发了新型的载有VEGF的肝素/聚-1-赖氨酸(Hep / PLL)颗粒并将其固定在多巴胺涂层的钛表面上。随后表征了所制备颗粒的尺寸,分布,ζ电势和形态。评估了固定化颗粒后表面理化性质的变化对血液相容性和细胞相容性的影响。表面修饰的载有VEGF的颗粒显着抑制了血小板的粘附和活化,并有效地促进了内皮祖细胞和内皮细胞的增殖和存活。此外,Hep / PLL颗粒也有利于控制VEGF的长期释放,这可能有助于内皮再生。总之,将载有VEGF的Hep / PLL颗粒成功固定在Ti表面上,生物相容性得到了显着改善。这项研究证明了用于临床用途的支架表面多功能修饰的潜在应用。 (c)2014 Wiley Periodicals,Inc.J Biomed Mater Res Part A:103A:2024-2034,2015。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号